England’s NICE Says Severity Modifier Working, But Industry Wants Cost Restrictions Lifted

The UK government should remove a cost-neutrality restriction on England’s health technology assessment institute, NICE, that limits the value it places on medicines for severe conditions, says industry body the ABPI.